Which genes drive EGFR resistance?
data.csv gene · log2fc · p_value CSV · 2,418 rows
In plain English. Attach a CSV to ground the answer in your own data.
Now in private beta
Your on demand co-bioinformatician
Ask in plain English. Kasvu Discovery queries 60+ research data sources in parallel, cites every one, and turns the answer into a publication-ready figure.
60+
Integrated data sources
Seconds
To comprehensive answers
100%
Traceable & citable
AI-Powered
Synthesis & intelligence
Built for researchers
All the data. All the context.
One intelligent agent.
Kasvu Discovery brings together the most comprehensive biomedical data with state-of-the-art AI to help you uncover meaning, faster.
-
60+ curated data sources
Genomic, clinical, variant, drug, and literature data. All integrated. Always up to date.
-
Natural-language enquiries
Ask anything in plain English. No schemas. No syntax. Just answers.
-
Publication-ready figures
Manhattan plots, volcano plots, heatmaps, and more — generated in seconds.
How it works
In conversation with science.
-
You ask -
Discovery plans Lead agent · dispatching- Target
- Association
- Oncology
- Literature
A lead agent decomposes the question and dispatches specialist sub-agents in parallel.
-
Cited answer EGFR T790M emerges in ~50% of resistant tumors, with MET amplification and HER2 mutations as secondary drivers…
PMID:38291045NCT04356729Streaming prose with inline figures, linked sources, and a reasoning graph — see what was queried, when, and where each claim came from.
What researchers say
Trusted by your peers.
-
Kasvu Discovery returns results in a structured, visual format that a non-bioinformatician can act on directly. It's easy to use, continuously improving, and a strong addition to our research toolkit.
-
I am impressed! Kasvu Discovery captured all the key information I was trying to put together. Nice to see a literature review can be done with one prompt, and you have the full big picture of the field you are in.
Forget ChatGPT
A bioinformatics specialist. Not a generalist.
Built for research from the ground up — querying live data sources, not frozen training data.
Kasvu Discovery Specialist 
ChatGPT / LLMs General-purpose Data source Live queries to 60+ research data sources Training set, frozen at a cut-off date
Citations Every claim linked to a real PMID, NCT, or DB record Often hallucinated or missing
Figures Manhattan & volcano plots — built from queried data Generic charts, no real data
Specialization Specialist sub-agents — target, oncology & literature General-purpose assistant
Data sources
Data source inventory.
Kasvu Discovery connects you to the most comprehensive biomedical data across genomics, literature, clinical evidence, and more — all kept current and ready to query.
-
Genome
Genomic variants, structural alterations, and population genetics.
-
Transcriptome
Gene and transcript expression across conditions, tissues, and time.
-
Proteome
Protein abundance, modifications, and interactions at scale.
-
Phenome
Clinical phenotypes, disease traits, and patient outcomes.
-
Therapeutics
Drug-target evidence, drug sensitivity, ADCs, antibody sequences, and clinical trials.
-
Ont & Lit
Disease ontologies, pathway/function, tissue/anatomy, literature corpora.
-
Visualization
3D protein structures, homology and isoform models, subcellular localization.
Designed for impact
Accelerate discovery across your research.
-
Target Identification
Find and prioritize novel therapeutic targets with multi-omic evidence.
-
Biomarker Discovery
Discover and validate biomarkers across diseases and patient cohorts.
-
Drug Repurposing
Identify new indications for existing drugs with confidence and speed.
-
Pathway Analysis
Understand complex biology with pathway-aware context and data.
-
Clinical Insights
Translate discoveries into actionable insights for better outcomes.
Founding seats
Research intelligence, priced fairly.
500 founding seats 412 remaining
-
Academic For university researchers and PhD students.
€ 149 /mo € 108 /moApply for Academic accessBilled monthly · save 28% annually Billed annually · €1,296/yr · save 28%- Full platform access — all current features
- All future updates and new integrations
- Verified institutional email required
- Non-commercial research use only
- Annual re-verification
- Access to academic user community
Requires verified institutional email — non-institutional emails route through a manual approval queue.
- Most popular
Founding Member For commercial and clinical researchers.
€ 390 /mo € 325 /moBecome a Founding MemberBilled monthly · save 17% annually Billed annually · €3,900/yr · save 17%- Full platform access — all current features
- All future updates and new integrations
- Priority access to new database integrations
- Direct input to the product roadmap
- Founding Member badge (#001–#500)
- Dedicated onboarding session
- Access to Founding Member community
Lifetime price lock — your rate never increases as long as your subscription is active.
-
Small Pharma / Biotech For small commercial research teams and biotech companies.
€ 790 /mo € 659 /moUpgrade to PharmaBilled monthly · save 17% annually Billed annually · €7,908/yr · save 17%- Everything in Founding Member, and:
- Higher fair-use ceilings
- Priority support with 1-day response SLA
- Increased token allowance per month
- Priority model access at peak times
- Early access to clinical data connectors
- No seat cap — invite your team
-
Enterprise For pharma, large biotech, CROs, and hospital systems.
Custom Tailored to your team and use caseContact sales- Team seat management
- SSO and enterprise authentication
- Dedicated customer success manager
- Custom data integrations
- SLA and uptime guarantees
- Invoice billing and purchase orders
- Security review and DPA support